Learn More
Apexbio Technology LLC ONX-0914 (PR-957) 960374-59-8 100mg

Supplier: Apexbio Technology LLC A4011100
ONX-0914 (PR-957) is a selective inhibitor targeting the immunoproteasome subunit 5i (LMP7) a proteolytic component involved in antigenic peptide processing for MHC class I presentation By reversibly binding the 5i-specific catalytic pocket ONX-0914 impairs the production of pro-inflammatory cytokines in activated human peripheral blood mononuclear cells (PBMCs) and suppresses IL-17 secretion during Th17 cell differentiation ONX-0914 has been employed experimentally in preclinical models of autoimmune conditions such as arthritis colitis and diabetes Reported IC50 values are approximately 5 15 nM for the 5i subunit demonstrating selective preference over constitutive proteasome subunits
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.